Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109477582> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2109477582 endingPage "250" @default.
- W2109477582 startingPage "245" @default.
- W2109477582 abstract "Assessment of the efficacy and safety of TAK-875 (a novel GPR40 agonist) in Japanese patients with type 2 diabetes inadequately controlled by diet/exercise.This was a phase II, multicenter, randomized, double-blind, parallel-group, placebo-controlled, 12-week dose-ranging evaluation of TAK-875 (6.25-200 mg once daily) with the primary end point of change in A1C at week 12. A nonblinded group received 1 mg glimepiride once daily as an active control.A total of 396 patients were randomized to receive TAK-875 (n = 299), placebo (n = 48), or glimepiride (n = 49). The least square mean changes in A1C at week 12 from baseline were as follows: 0.09% in the placebo group; -0.54, -0.67, -0.88, -1.27, -1.29, and -1.40% in the 6.25-, 12.5-, 25-, 50-, 100-, and 200-mg TAK-875 groups, respectively; and -1.32% in the 1-mg glimepiride group. All TAK-875 groups had statistically significant reductions in A1C compared with placebo (P < 0.0001), and those receiving ≥50 mg TAK-875 achieved reductions in A1C equivalent to those with glimepiride. Results for other glycemic parameters, including improvements during a meal tolerance test, mirrored these positive findings with TAK-875. There were no significant differences in incidence of adverse events among the groups and no dose-dependent changes in tolerability. Hypoglycemic episodes were reported in 0.7% of patients in the TAK-875 groups and in 4.1% of the glimepiride group.TAK-875 produced clinically and statistically significant improvements in glycemic control in patients with type 2 diabetes inadequately controlled by diet and exercise, and it was well tolerated with a lower propensity to cause hypoglycemia." @default.
- W2109477582 created "2016-06-24" @default.
- W2109477582 creator A5003841044 @default.
- W2109477582 creator A5028042084 @default.
- W2109477582 creator A5036190568 @default.
- W2109477582 date "2013-01-17" @default.
- W2109477582 modified "2023-10-16" @default.
- W2109477582 title "Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes" @default.
- W2109477582 cites W1985487963 @default.
- W2109477582 cites W2054951377 @default.
- W2109477582 cites W2066702528 @default.
- W2109477582 cites W2077936393 @default.
- W2109477582 cites W2128326754 @default.
- W2109477582 cites W2138309074 @default.
- W2109477582 cites W2147024197 @default.
- W2109477582 cites W2150568560 @default.
- W2109477582 cites W2150854800 @default.
- W2109477582 cites W2163448046 @default.
- W2109477582 cites W2165816400 @default.
- W2109477582 doi "https://doi.org/10.2337/dc12-0872" @default.
- W2109477582 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3554318" @default.
- W2109477582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23086138" @default.
- W2109477582 hasPublicationYear "2013" @default.
- W2109477582 type Work @default.
- W2109477582 sameAs 2109477582 @default.
- W2109477582 citedByCount "87" @default.
- W2109477582 countsByYear W21094775822013 @default.
- W2109477582 countsByYear W21094775822014 @default.
- W2109477582 countsByYear W21094775822015 @default.
- W2109477582 countsByYear W21094775822016 @default.
- W2109477582 countsByYear W21094775822017 @default.
- W2109477582 countsByYear W21094775822018 @default.
- W2109477582 countsByYear W21094775822019 @default.
- W2109477582 countsByYear W21094775822020 @default.
- W2109477582 countsByYear W21094775822021 @default.
- W2109477582 countsByYear W21094775822022 @default.
- W2109477582 countsByYear W21094775822023 @default.
- W2109477582 crossrefType "journal-article" @default.
- W2109477582 hasAuthorship W2109477582A5003841044 @default.
- W2109477582 hasAuthorship W2109477582A5028042084 @default.
- W2109477582 hasAuthorship W2109477582A5036190568 @default.
- W2109477582 hasBestOaLocation W21094775821 @default.
- W2109477582 hasConcept C126322002 @default.
- W2109477582 hasConcept C134018914 @default.
- W2109477582 hasConcept C142724271 @default.
- W2109477582 hasConcept C168563851 @default.
- W2109477582 hasConcept C197934379 @default.
- W2109477582 hasConcept C204787440 @default.
- W2109477582 hasConcept C27081682 @default.
- W2109477582 hasConcept C2776307423 @default.
- W2109477582 hasConcept C2776312127 @default.
- W2109477582 hasConcept C2777180221 @default.
- W2109477582 hasConcept C2778375690 @default.
- W2109477582 hasConcept C2780473172 @default.
- W2109477582 hasConcept C2780668416 @default.
- W2109477582 hasConcept C2991744798 @default.
- W2109477582 hasConcept C555293320 @default.
- W2109477582 hasConcept C71924100 @default.
- W2109477582 hasConceptScore W2109477582C126322002 @default.
- W2109477582 hasConceptScore W2109477582C134018914 @default.
- W2109477582 hasConceptScore W2109477582C142724271 @default.
- W2109477582 hasConceptScore W2109477582C168563851 @default.
- W2109477582 hasConceptScore W2109477582C197934379 @default.
- W2109477582 hasConceptScore W2109477582C204787440 @default.
- W2109477582 hasConceptScore W2109477582C27081682 @default.
- W2109477582 hasConceptScore W2109477582C2776307423 @default.
- W2109477582 hasConceptScore W2109477582C2776312127 @default.
- W2109477582 hasConceptScore W2109477582C2777180221 @default.
- W2109477582 hasConceptScore W2109477582C2778375690 @default.
- W2109477582 hasConceptScore W2109477582C2780473172 @default.
- W2109477582 hasConceptScore W2109477582C2780668416 @default.
- W2109477582 hasConceptScore W2109477582C2991744798 @default.
- W2109477582 hasConceptScore W2109477582C555293320 @default.
- W2109477582 hasConceptScore W2109477582C71924100 @default.
- W2109477582 hasIssue "2" @default.
- W2109477582 hasLocation W21094775821 @default.
- W2109477582 hasLocation W21094775822 @default.
- W2109477582 hasLocation W21094775823 @default.
- W2109477582 hasLocation W21094775824 @default.
- W2109477582 hasOpenAccess W2109477582 @default.
- W2109477582 hasPrimaryLocation W21094775821 @default.
- W2109477582 hasRelatedWork W1966047811 @default.
- W2109477582 hasRelatedWork W1986510336 @default.
- W2109477582 hasRelatedWork W2003042623 @default.
- W2109477582 hasRelatedWork W202460821 @default.
- W2109477582 hasRelatedWork W2068849886 @default.
- W2109477582 hasRelatedWork W2109235243 @default.
- W2109477582 hasRelatedWork W2147606462 @default.
- W2109477582 hasRelatedWork W2560350129 @default.
- W2109477582 hasRelatedWork W3023502736 @default.
- W2109477582 hasRelatedWork W4247943178 @default.
- W2109477582 hasVolume "36" @default.
- W2109477582 isParatext "false" @default.
- W2109477582 isRetracted "false" @default.
- W2109477582 magId "2109477582" @default.
- W2109477582 workType "article" @default.